Alert

알림

State Street SPDR S&P Bio... (XBI)

NYSEArca: XBI · 실시간 가격 · USD

160.11

+0.58 (0.36%)

종가 기준: Aug 18, 2026, 3:59 PM

165.26

+3.22%

프리마켓: 8:52 AM

0.36% (1D)

매수호가	0
시가총액	n/a
운용자산	9.63B
순자산가치	159.47
베타	1.14
EPS (최근 12개월)	n/a
P/E (최근 12개월)	n/a
발행 주식수	n/a
설정일	Jan 31, 2006

매도호가	160.6
거래량	6,285,192
평균 거래량 (20일)	8,752,762
시가	158.34
전일 종가	159.53
당일 변동폭	157.88 - 160.59
52주 변동폭	88.18 - 165.71
편입 종목	n/a
총보수	0.35%

XBI 정보

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

자산군 Equity

종목코드 XBI

설정일 Jan 31, 2006

운용사 State Street Investment Management

웹사이트 펀드 홈페이지

거래소 NYSEArca

주요 섹터

섹터	비중 %
Healthcare	99.60%
Financial Services	0.40%

전체 섹터 보기

상위 10종목 자산의 13.97%

이름	종목코드	비중
Apogee Therapeutics ...	APGE	1.65%
Oruka Therapeutics I...	ORKA	1.53%
Dianthus Therapeutic...	DNTH	1.42%
Erasca Inc	ERAS	1.38%
Twist Bioscience Cor...	TWST	1.37%
Kymera Therapeutics ...	KYMR	1.34%
Spyre Therapeutics I...	SYRE	1.33%
Revolution Medicines...	RVMD	1.32%
Cg Oncology Inc	CGON	1.32%
Protagonist Therapeu...	PTGX	1.31%

편입 종목 더 보기

배당 배당수익률 0.36%

배당락일	금액	지급일
Jun 22, 2026	$0.1380	n/a
Dec 22, 2025	$0.4070	n/a
Sep 22, 2025	$0.0270	n/a
Jun 23, 2025	$0.0070	n/a
Mar 24, 2025	$0.0050	n/a

전체 배당 이력

뉴스

48분 전 · The Wall Street Journal

⚡Flash Heard: Why Healthcare Is Partying Like It’s Late 2020

Moderna and Merck are surging today after the two companies said their experimental mRNA-based treatment succeeded in a late-stage study of high-risk melanoma patients. The SPDR S&P Biotech ETF (XBI)...

2시간 전 · Barrons.com

Biotech Stocks Are Booming. What This Top Fund Is Buying Now.

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3%

4시간 전 · Motley Fool

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

XBI's lower fees and 155-stock portfolio contrast sharply with FBT's concentrated 30-holding approach, though FBT has experienced less volatility over the past five years.

22시간 전 · Motley Fool

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?

PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.

1주 전 · Motley Fool

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?

XBI surged 80% in one year but endured a 54% drawdown, while IXJ delivered steadier gains with half volatility and a 1.4% dividend.

2 페이지 중 1